Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines

BACKGROUND: Glioblastomas (GBM) are the most common malignant type of primary brain tumor. GBM are intensively treated with surgery and combined radiochemotherapy using X-irradiation and temozolomide (TMZ) but they are still associated with an extremely poor prognosis, urging for the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedel, Matthias, Struve, Nina, Müller-Goebel, Justus, Köcher, Sabrina, Petersen, Cordula, Dikomey, Ekkehard, Rothkamm, Kai, Kriegs, Malte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308705/
https://www.ncbi.nlm.nih.gov/pubmed/27542273
http://dx.doi.org/10.18632/oncotarget.11328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308705/
https://www.ncbi.nlm.nih.gov/pubmed/27542273
http://dx.doi.org/10.18632/oncotarget.11328

Ejemplares similares